标题
The IL-23/IL-17 Pathway in Inflammatory Skin Diseases: From Bench to Bedside
作者
关键词
-
出版物
Frontiers in Immunology
Volume 11, Issue -, Pages -
出版商
Frontiers Media SA
发表日期
2020-11-17
DOI
10.3389/fimmu.2020.594735
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Clinical and histopathological characterization of eczematous eruptions occurring in course of anti IL-17 treatment: a case series and review of the literature
- (2020) G. Caldarola et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Risk of tuberculosis reactivation during IL‐17 inhibitor therapy for psoriasis: A systematic review
- (2020) E. Fowler et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- The role of the IL‐23/Th17 pathway in cardio‐metabolic comorbidity associated with psoriasis
- (2020) A Egeberg et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Phenotypic switch to eczema in patients receiving biologics for plaque psoriasis: a systematic review
- (2020) A. Al‐Janabi et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Bimekizumab in patients with active psoriatic arthritis: results from a 48-week, randomised, double-blind, placebo-controlled, dose-ranging phase 2b trial
- (2020) Christopher T Ritchlin et al. LANCET
- Long-term efficacy and safety of brodalumab in psoriasis through 120 weeks and after withdrawal and retreatment: subgroup analysis of a randomised phase 3 trial (AMAGINE-1)
- (2020) K. Papp et al. BRITISH JOURNAL OF DERMATOLOGY
- Ustekinumab for the treatment of moderate‐to‐severe plaque psoriasis in paediatric patients (≥ 6 to < 12 years of age): efficacy, safety, pharmacokinetic and biomarker results from the open‐label CADMUS Jr study
- (2020) S. Philipp et al. BRITISH JOURNAL OF DERMATOLOGY
- Structural Analysis Reveals that the Cytokine IL-17F Forms a Homodimeric Complex with Receptor IL-17RC to Drive IL-17RA-Independent Signaling
- (2020) Arnaud Goepfert et al. IMMUNITY
- The Effect of Subcutaneous Brodalumab upon Clinical Disease Activity in Hidradenitis Suppurativa: An Open Label Cohort Study
- (2020) John W. Frew et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Bimekizumab for patients with moderate-to-severe plaque psoriasis: 60-week results from BE ABLE 2, a randomized, double-blinded, placebo-controlled phase 2b extension study
- (2020) Andrew Blauvelt et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Guselkumab in biologic-naive patients with active psoriatic arthritis (DISCOVER-2): a double-blind, randomised, placebo-controlled phase 3 trial
- (2020) Philip J Mease et al. LANCET
- Guselkumab in patients with active psoriatic arthritis who were biologic-naive or had previously received TNFα inhibitor treatment (DISCOVER-1): a double-blind, randomised, placebo-controlled phase 3 trial
- (2020) Atul Deodhar et al. LANCET
- Safety of ixekizumab in adult patients with plaque psoriasis, psoriatic arthritis and axial spondyloarthritis: data from 21 clinical trials
- (2020) Mark C Genovese et al. RHEUMATOLOGY
- Evaluation of Ixekizumab Treatment for Patients With Pityriasis Rubra Pilaris
- (2020) Dylan Haynes et al. JAMA Dermatology
- EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2019 update
- (2020) Laure Gossec et al. ANNALS OF THE RHEUMATIC DISEASES
- Secukinumab shows high and sustained efficacy in nail psoriasis: 2.5‐year results from the randomized placebo‐controlled TRANSFIGURE study
- (2020) K. Reich et al. BRITISH JOURNAL OF DERMATOLOGY
- Excessive Polyamine Generation in Keratinocytes Promotes Self-RNA Sensing by Dendritic Cells in Psoriasis
- (2020) Fangzhou Lou et al. IMMUNITY
- Hectd3 promotes pathogenic Th17 lineage through Stat3 activation and Malt1 signaling in neuroinflammation
- (2019) Jonathan J. Cho et al. Nature Communications
- Imiquimod-Induced Psoriasis in Mice Depends on the IL-17 Signaling of Keratinocytes
- (2019) Sonja Moos et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- IL-17E (IL-25) enhances innate immune responses during skin inflammation
- (2019) Luisa Senra et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Open‐label, investigator‐initiated, single‐site exploratory trial evaluating secukinumab, an anti‐interleukin‐17A monoclonal antibody, for patients with moderate‐to‐severe hidradenitis suppurativa
- (2019) L. Prussick et al. BRITISH JOURNAL OF DERMATOLOGY
- Eczematous eruption during anti‐interleukin 17 treatment of psoriasis: an emerging condition
- (2019) M. Napolitano et al. BRITISH JOURNAL OF DERMATOLOGY
- Brodalumab in the treatment of moderate-to-severe psoriasis in patients who have previously failed treatment with anti-interleukin-17A therapies
- (2019) Grace Kimmel et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- CCL3, IL‐7, IL‐13 and IFNγ transcripts are increased in skin's biopsy of systemic sclerosis
- (2019) Rafaela Silva Guimarães Gonçalves et al. EXPERIMENTAL DERMATOLOGY
- Anti-IL-17A and IL-23p19 antibodies but not anti-TNFα antibody induce expansion of regulatory T cells and restoration of their suppressive function in imiquimod-induced psoriasiform dermatitis
- (2019) Teruo Shimizu et al. JOURNAL OF DERMATOLOGICAL SCIENCE
- A Phase IV, Randomized, Double-Blind, Placebo-Controlled Crossover Study of the Effects of Ustekinumab on Vascular Inflammation in Psoriasis (the VIP-U trial)
- (2019) J.M. Gelfand et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Long-term efficacy and safety of brodalumab in the treatment of psoriasis: 120-week results from the randomized, double-blind, placebo- and active comparator–controlled phase 3 AMAGINE-2 trial
- (2019) Luis Puig et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- c-Kit-positive ILC2s exhibit an ILC3-like signature that may contribute to IL-17-mediated pathologies
- (2019) Jochem H. Bernink et al. NATURE IMMUNOLOGY
- Interleukin-17 receptor D constitutes an alternative receptor for interleukin-17A important in psoriasis-like skin inflammation
- (2019) Yang Su et al. Science Immunology
- Efficacy and safety of tildrakizumab for plaque psoriasis with continuous dosing, treatment interruption, dose adjustments, and switching from etanercept: results from phase 3 studies
- (2019) A.B. Kimball et al. BRITISH JOURNAL OF DERMATOLOGY
- IL-12/IL-23 neutralization is ineffective for alopecia areata in mice and humans
- (2019) Luana S. Ortolan et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Characteristic Pattern of IL-17RA, IL-17RB, and IL-17RC in Monocytes/Macrophages and Mast Cells From Patients With Bullous Pemphigoid
- (2019) Stéphane Nesmond et al. Frontiers in Immunology
- Evolution of pathologic T-cell subsets in atopic dermatitis from infancy to adulthood
- (2019) Tali Czarnowicki et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Secukinumab provides sustained low rates of radiographic progression in psoriatic arthritis: 52-week results from a phase 3 study, FUTURE 5
- (2019) Désirée van der Heijde et al. RHEUMATOLOGY
- Chronic mucocutaneous candidiasis and connective tissue disorder in humans with impaired JNK1-dependent responses to IL-17A/F and TGF-β
- (2019) Juan Li et al. Science Immunology
- Short-term transcriptional response to IL-17 receptor-A antagonism in the treatment of psoriasis
- (2019) Lewis E. Tomalin et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- IL-17 induces cellular stress microenvironment of melanocytes to promote autophagic cell apoptosis in vitiligo
- (2018) Jia Zhou et al. FASEB JOURNAL
- An Interleukin-25-Mediated Autoregulatory Circuit in Keratinocytes Plays a Pivotal Role in Psoriatic Skin Inflammation
- (2018) Miao Xu et al. IMMUNITY
- Gain-of-Function Mutation of Card14 Leads to Spontaneous Psoriasis-like Skin Inflammation through Enhanced Keratinocyte Response to IL-17A
- (2018) Mingchao Wang et al. IMMUNITY
- The imbalance of circulating T helper subsets and regulatory T cells in patients with LRBA deficiency: Correlation with disease severity
- (2018) Gholamreza Azizi et al. JOURNAL OF CELLULAR PHYSIOLOGY
- A systematic review of ustekinumab in the treatment of atopic dermatitis
- (2018) Yunlei Pan et al. JOURNAL OF DERMATOLOGICAL TREATMENT
- Neutralization of IL-17C Reduces Skin Inflammation in Mouse Models of Psoriasis and Atopic Dermatitis
- (2018) Nick Vandeghinste et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- IL-17–Mediated Immunity Controls Skin Infection and T Helper 1 Response during Experimental Microsporum canis Dermatophytosis
- (2018) Verónica L. Burstein et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Maintenance of Skin Clearance With Ixekizumab Treatment of Psoriasis: Three-Year Results From the UNCOVER-3 Study
- (2018) Craig Leonardi et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Ustekinumab treatment is associated with decreased systemic and vascular inflammation in patients with moderate to severe psoriasis: Feasibility study using 18F-fluorodeoxyglucose positron emission tomography-computed tomography
- (2018) Byung-Soo Kim et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Psoriasis and the risk of diabetes: A prospective population-based cohort study
- (2018) Marilyn T. Wan et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Dual neutralization of both interleukin 17A and interleukin 17F with bimekizumab in patients with psoriasis: Results from BE ABLE 1, a 12-week randomized, double-blinded, placebo-controlled phase 2b trial
- (2018) Kim A. Papp et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Biologics for pityriasis rubra pilaris treatment: A review of the literature
- (2018) Monica Napolitano et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Role of T helper 17 cells and T regulatory cells in alopecia areata: comparison of lesion and serum cytokine between controls and patients
- (2018) S.-H. Loh et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Secukinumab demonstrates high sustained efficacy and a favourable safety profile in patients with moderate-to-severe psoriasis through 5 years of treatment (SCULPTURE Extension Study)
- (2018) R. Bissonnette et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Efficacy and safety of guselkumab in patients with active psoriatic arthritis: a randomised, double-blind, placebo-controlled, phase 2 study
- (2018) Atul Deodhar et al. LANCET
- Involvement of the IL23/Th17 Pathway in the Pathogenesis of Tunisian Pemphigus Foliaceus
- (2018) M. Ben Jmaa et al. MEDIATORS OF INFLAMMATION
- Association of Hidradenitis Suppurativa With T Helper 1/T Helper 17 Phenotypes
- (2018) Rahel Thomi et al. JAMA Dermatology
- IL-1-IL-17 Signaling Axis Contributes to Fibrosis and Inflammation in Two Different Murine Models of Systemic Sclerosis
- (2018) Min-Jung Park et al. Frontiers in Immunology
- Efficacy and safety of secukinumab treatment in adults with extensive alopecia areata
- (2018) Emma Guttman-Yassky et al. ARCHIVES OF DERMATOLOGICAL RESEARCH
- Imbalance between T helper 17 and regulatory T cell subsets plays a significant role in the pathogenesis of systemic sclerosis
- (2018) Cuiling Mo et al. BIOMEDICINE & PHARMACOTHERAPY
- Efficacy and safety of risankizumab in moderate-to-severe plaque psoriasis (UltIMMa-1 and UltIMMa-2): results from two double-blind, randomised, placebo-controlled and ustekinumab-controlled phase 3 trials
- (2018) Kenneth B Gordon et al. LANCET
- Efficacy and safety of brodalumab in patients with psoriasis who had inadequate responses to ustekinumab: subgroup analysis of two randomized phase III trials
- (2018) R.G. Langley et al. BRITISH JOURNAL OF DERMATOLOGY
- A role for Th1-like Th17 cells in the pathogenesis of inflammatory and autoimmune disorders
- (2018) Ali N. Kamali et al. MOLECULAR IMMUNOLOGY
- RORγt inhibition selectively targets IL-17 producing iNKT and γδ-T cells enriched in Spondyloarthritis patients
- (2018) Koen Venken et al. Nature Communications
- β-Defensin 2 is a responsive biomarker of IL-17A–driven skin pathology in patients with psoriasis
- (2017) Frank Kolbinger et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Potential role of IL-17-producing CD4/CD8 double negative αβ T cells in psoriatic skin inflammation in a TPA-induced STAT3C transgenic mouse model
- (2017) Azumi Ueyama et al. JOURNAL OF DERMATOLOGICAL SCIENCE
- Ustekinumab treatment of pityriasis rubra pilaris: A report of five cases
- (2017) Monica Napolitano et al. JOURNAL OF DERMATOLOGY
- IL-17A–Induced PLET1 Expression Contributes to Tissue Repair and Colon Tumorigenesis
- (2017) Jarod A. Zepp et al. JOURNAL OF IMMUNOLOGY
- Hidradenitis Suppurativa Is Characterized by Dysregulation of the Th17:Treg Cell Axis, Which Is Corrected by Anti-TNF Therapy
- (2017) Barry Moran et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Short- and long-term safety outcomes with ixekizumab from 7 clinical trials in psoriasis: Etanercept comparisons and integrated data
- (2017) Bruce Strober et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Increased interleukin (IL)-17 serum levels in patients with hidradenitis suppurativa: Implications for treatment with anti-IL-17 agents
- (2017) Łukasz Matusiak et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Efficacy and safety of ixekizumab for the treatment of moderate-to-severe plaque psoriasis: Results through 108 weeks of a randomized, controlled phase 3 clinical trial (UNCOVER-3)
- (2017) Andrew Blauvelt et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Ixekizumab for the treatment of patients with active psoriatic arthritis and an inadequate response to tumour necrosis factor inhibitors: results from the 24-week randomised, double-blind, placebo-controlled period of the SPIRIT-P2 phase 3 trial
- (2017) Peter Nash et al. LANCET
- Tildrakizumab versus placebo or etanercept for chronic plaque psoriasis (reSURFACE 1 and reSURFACE 2): results from two randomised controlled, phase 3 trials
- (2017) Kristian Reich et al. LANCET
- Th1/Th17-Related Cytokines and Chemokines and Their Implications in the Pathogenesis of Pemphigus Vulgaris
- (2017) Rodolfo Pessato Timoteo et al. MEDIATORS OF INFLAMMATION
- Risankizumab versus Ustekinumab for Moderate-to-Severe Plaque Psoriasis
- (2017) Kim A. Papp et al. NEW ENGLAND JOURNAL OF MEDICINE
- Secukinumab sustains improvement in signs and symptoms of psoriatic arthritis: 2 year results from the phase 3 FUTURE 2 study
- (2017) Iain B McInnes et al. RHEUMATOLOGY
- Interleukin 23–Helper T Cell 17 Axis as a Treatment Target for Pityriasis Rubra Pilaris
- (2017) Laurence Feldmeyer et al. JAMA Dermatology
- Ixekizumab, an interleukin-17A specific monoclonal antibody, for the treatment of biologic-naive patients with active psoriatic arthritis: results from the 24-week randomised, double-blind, placebo-controlled and active (adalimumab)-controlled period of the phase III trial SPIRIT-P1
- (2016) Philip J Mease et al. ANNALS OF THE RHEUMATIC DISEASES
- Efficacy and safety of brodalumab in patients with generalized pustular psoriasis and psoriatic erythroderma: results from a 52-week, open-label study
- (2016) K. Yamasaki et al. BRITISH JOURNAL OF DERMATOLOGY
- Ustekinumab in hidradenitis suppurativa: clinical results and a search for potential biomarkers in serum
- (2016) J.L. Blok et al. BRITISH JOURNAL OF DERMATOLOGY
- A prospective phase III, randomized, double-blind, placebo-controlled study of brodalumab in patients with moderate-to-severe plaque psoriasis
- (2016) K.A. Papp et al. BRITISH JOURNAL OF DERMATOLOGY
- IL-17 Receptor Signaling in Oral Epithelial Cells Is Critical for Protection against Oropharyngeal Candidiasis
- (2016) Heather R. Conti et al. Cell Host & Microbe
- Efficacy and safety of ustekinumab treatment in adults with moderate-to-severe atopic dermatitis
- (2016) Saakshi Khattri et al. EXPERIMENTAL DERMATOLOGY
- The Costimulatory Receptor OX40 Inhibits Interleukin-17 Expression through Activation of Repressive Chromatin Remodeling Pathways
- (2016) Xiang Xiao et al. IMMUNITY
- Keratinocyte-Derived IL-17E Contributes to Inflammation in Psoriasis
- (2016) Luisa Senra et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Chronic skin inflammation leads to bone loss by IL-17–mediated inhibition of Wnt signaling in osteoblasts
- (2016) Özge Uluçkan et al. Science Translational Medicine
- Tiam1/Rac1 complex controls Il17a transcription and autoimmunity
- (2016) Ahmed T. Kurdi et al. Nature Communications
- IL-17-producing γδ T cells enhance bone regeneration
- (2016) Takehito Ono et al. Nature Communications
- Successful Treatment of Refractory Pityriasis Rubra Pilaris With Secukinumab
- (2016) Daniel Schuster et al. JAMA Dermatology
- Mutual upregulation of endothelin-1 and IL-25 in atopic dermatitis
- (2015) M. K. Aktar et al. ALLERGY
- Increased expression of interleukin-17 pathway genes in nonlesional skin of moderate-to-severe psoriasis vulgaris
- (2015) A. Chiricozzi et al. BRITISH JOURNAL OF DERMATOLOGY
- Keratinocytes and neutrophils are important sources of proinflammatory molecules in hidradenitis suppurativa
- (2015) A.L. Lima et al. BRITISH JOURNAL OF DERMATOLOGY
- Dysregulated cytokine expression in lesional and nonlesional skin in hidradenitis suppurativa
- (2015) G. Kelly et al. BRITISH JOURNAL OF DERMATOLOGY
- The elevated expression of Th17-related cytokines and receptors is associated with skin lesion severity in early systemic sclerosis
- (2015) Yan Zhou et al. HUMAN IMMUNOLOGY
- Growth Factor FGF2 Cooperates with Interleukin-17 to Repair Intestinal Epithelial Damage
- (2015) Xinyang Song et al. IMMUNITY
- T-helper 17 cytokines (interleukins 17, 21, 22, and 6, and tumor necrosis factor-α) in patients with alopecia areata: association with clinical type and severity
- (2015) Mona A. Atwa et al. INTERNATIONAL JOURNAL OF DERMATOLOGY
- The Asian atopic dermatitis phenotype combines features of atopic dermatitis and psoriasis with increased TH17 polarization
- (2015) Shinji Noda et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Human mast cells are major IL-22 producers in patients with psoriasis and atopic dermatitis
- (2015) Shunya Mashiko et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Imbalance of T-helper 17 and regulatory T cells in patients with alopecia areata
- (2015) Yu-Mei Han et al. JOURNAL OF DERMATOLOGY
- A novel IL-17 signaling pathway controlling keratinocyte proliferation and tumorigenesis via the TRAF4–ERK5 axis
- (2015) Ling Wu et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Melanocyte antigen triggers autoimmunity in human psoriasis
- (2015) Akiko Arakawa et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Syk Mediates IL−17-Induced CCL20 Expression by Targeting Act1-Dependent K63-Linked Ubiquitination of TRAF6
- (2015) Nan-Lin Wu et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Dissecting susceptibility from exogenous triggers: the model of alopecia areata and associated inflammatory skin diseases
- (2015) N. Garzorz et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Secukinumab, a human anti-interleukin-17A monoclonal antibody, in patients with psoriatic arthritis (FUTURE 2): a randomised, double-blind, placebo-controlled, phase 3 trial
- (2015) Iain B McInnes et al. LANCET
- TH17 cells promote microbial killing and innate immune sensing of DNA via interleukin 26
- (2015) Stephan Meller et al. NATURE IMMUNOLOGY
- Secukinumab Inhibition of Interleukin-17A in Patients with Psoriatic Arthritis
- (2015) Philip J. Mease et al. NEW ENGLAND JOURNAL OF MEDICINE
- Enhanced meta-analysis and replication studies identify five new psoriasis susceptibility loci
- (2015) Lam C. Tsoi et al. Nature Communications
- Comparative Genomic Profiling of Synovium Versus Skin Lesions in Psoriatic Arthritis
- (2015) Jennifer Belasco et al. Arthritis & Rheumatology
- IL-17A gene transfer induces bone loss and epidermal hyperplasia associated with psoriatic arthritis
- (2014) Iannis E Adamopoulos et al. ANNALS OF THE RHEUMATIC DISEASES
- Interleukin 17 Drives Vascular Inflammation, Endothelial Dysfunction, and Arterial Hypertension in Psoriasis-Like Skin Disease
- (2014) Susanne Karbach et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Composition of Innate Lymphoid Cell Subsets in the Human Skin: Enrichment of NCR + ILC3 in Lesional Skin and Blood of Psoriasis Patients
- (2014) Marcel B.M. Teunissen et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Innate Immune Cell–Produced IL-17 Sustains Inflammation in Bullous Pemphigoid
- (2014) Sébastien Le Jan et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Overexpression of Interleukin-23 and Interleukin-17 in the Lesion of Pemphigus Vulgaris: A Preliminary Study
- (2014) Jixin Xue et al. MEDIATORS OF INFLAMMATION
- Secukinumab in Plaque Psoriasis — Results of Two Phase 3 Trials
- (2014) Richard G. Langley et al. NEW ENGLAND JOURNAL OF MEDICINE
- Increased frequency of Th17 cells in systemic sclerosis is related to disease activity and collagen overproduction
- (2014) Xiaoqin Yang et al. ARTHRITIS RESEARCH & THERAPY
- Interleukin-17A promotes functional activation of systemic sclerosis patient-derived dermal vascular smooth muscle cells by extracellular-regulated protein kinases signalling pathway
- (2014) Mengguo Liu et al. ARTHRITIS RESEARCH & THERAPY
- Heterogeneous expression pattern of interleukin 17A (IL-17A), IL-17F and their receptors in synovium of rheumatoid arthritis, psoriatic arthritis and osteoarthritis: possible explanation for nonresponse to anti-IL-17 therapy?
- (2014) Lisa GM van Baarsen et al. ARTHRITIS RESEARCH & THERAPY
- The antimicrobial peptide LL37 is a T-cell autoantigen in psoriasis
- (2014) Roberto Lande et al. Nature Communications
- Structure of the unique SEFIR domain from human interleukin 17 receptor A reveals a composite ligand-binding site containing a conserved α-helix for Act1 binding and IL-17 signaling
- (2014) Bing Zhang et al. ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY
- Myeloid marker S100A8/A9 and lymphocyte marker, soluble interleukin 2 receptor: biomarkers of hidradenitis suppurativa disease activity?
- (2013) C.W. Wieland et al. BRITISH JOURNAL OF DERMATOLOGY
- Long-term safety of ustekinumab in patients with moderate-to-severe psoriasis: final results from 5 years of follow-up
- (2013) K.A. Papp et al. BRITISH JOURNAL OF DERMATOLOGY
- T-helper and regulatory T-cell cytokines in the peripheral blood of patients with active alopecia areata
- (2013) M.K. Tembhre et al. BRITISH JOURNAL OF DERMATOLOGY
- Intrinsic atopic dermatitis shows similar TH2 and higher TH17 immune activation compared with extrinsic atopic dermatitis
- (2013) Mayte Suárez-Fariñas et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- A role for IL-25 and IL-33–driven type-2 innate lymphoid cells in atopic dermatitis
- (2013) Maryam Salimi et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Keratinocyte Overexpression of IL-17C Promotes Psoriasiform Skin Inflammation
- (2013) A. Johnston et al. JOURNAL OF IMMUNOLOGY
- The Deubiquitinase A20 Mediates Feedback Inhibition of Interleukin-17 Receptor Signaling
- (2013) A. V. Garg et al. Science Signaling
- IL-17A is essential for cell activation and inflammatory gene circuits in subjects with psoriasis
- (2012) James G. Krueger et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Progressive activation of TH2/TH22 cytokines and selective epidermal proteins characterizes acute and chronic atopic dermatitis
- (2012) Julia K. Gittler et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Interleukin-17-positive mast cells contribute to synovial inflammation in spondylarthritis
- (2011) Troy Noordenbos et al. ARTHRITIS AND RHEUMATISM
- Alterations in leucocyte subsets and histomorphology in normal-appearing perilesional skin and early and chronic hidradenitis suppurativa lesions
- (2011) H.H. van der Zee et al. BRITISH JOURNAL OF DERMATOLOGY
- IL-17 downregulates filaggrin and affects keratinocyte expression of genes associated with cellular adhesion
- (2011) Danuta Gutowska-Owsiak et al. EXPERIMENTAL DERMATOLOGY
- Pivotal Role of Dermal IL-17-Producing γδ T Cells in Skin Inflammation
- (2011) Yihua Cai et al. IMMUNITY
- Expression of the IL-23/Th17 pathway in lesions of hidradenitis suppurativa
- (2011) Christoph Schlapbach et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- IL-17 receptor and its functional significance in psoriatic arthritis
- (2011) Siba P. Raychaudhuri et al. MOLECULAR AND CELLULAR BIOCHEMISTRY
- Treatment with IL-17 prolongs the half-life of chemokine CXCL1 mRNA via the adaptor TRAF5 and the splicing-regulatory factor SF2 (ASF)
- (2011) Dongxu Sun et al. NATURE IMMUNOLOGY
- The inducible kinase IKKi is required for IL-17-dependent signaling associated with neutrophilia and pulmonary inflammation
- (2011) Katarzyna Bulek et al. NATURE IMMUNOLOGY
- Chronic Mucocutaneous Candidiasis in Humans with Inborn Errors of Interleukin-17 Immunity
- (2011) A. Puel et al. SCIENCE
- SEF/IL-17R (SEFIR) Is Not Enough
- (2010) Reiko M. Onishi et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Modulation of experimental autoimmune encephalomyelitis through TRAF3-mediated suppression of interleukin 17 receptor signaling
- (2010) Shu Zhu et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Chronic mucocutaneous candidiasis in APECED or thymoma patients correlates with autoimmunity to Th17-associated cytokines
- (2010) Kai Kisand et al. JOURNAL OF EXPERIMENTAL MEDICINE
- IL-17RC Is Required for Immune Signaling via an Extended SEF/IL-17R Signaling Domain in the Cytoplasmic Tail
- (2010) A. W. Ho et al. JOURNAL OF IMMUNOLOGY
- IL-25 in Atopic Dermatitis: A Possible Link between Inflammation and Skin Barrier Dysfunction?
- (2010) Malene Hvid et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Overrepresentation of IL-17A and IL-22 Producing CD8 T Cells in Lesional Skin Suggests Their Involvement in the Pathogenesis of Psoriasis
- (2010) Pieter C. M. Res et al. PLoS One
- Characterization of the interleukin-17 isoforms and receptors in lesional psoriatic skin
- (2009) C. Johansen et al. BRITISH JOURNAL OF DERMATOLOGY
- Serum cytokines and growth factor levels in Japanese patients with psoriasis
- (2009) H. Takahashi et al. CLINICAL AND EXPERIMENTAL DERMATOLOGY
- Filaggrin-deficient mice exhibit TH17-dominated skin inflammation and permissiveness to epicutaneous sensitization with protein antigen
- (2009) Michiko K. Oyoshi et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Broad defects in epidermal cornification in atopic dermatitis identified through genomic analysis
- (2009) Emma Guttman-Yassky et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- IL-22–producing “T22” T cells account for upregulated IL-22 in atopic dermatitis despite reduced IL-17–producing TH17 T cells
- (2009) Kristine E. Nograles et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Self-RNA–antimicrobial peptide complexes activate human dendritic cells through TLR7 and TLR8
- (2009) Dipyaman Ganguly et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Th17 Cytokines Stimulate CCL20 Expression in Keratinocytes In Vitro and In Vivo: Implications for Psoriasis Pathogenesis
- (2009) Erin G. Harper et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Increased numbers of circulating polyfunctional Th17 memory cells in patients with seronegative spondylarthritides
- (2008) Camilla Jandus et al. ARTHRITIS AND RHEUMATISM
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now